MedPath

Diabetes Mellitus treated with Medical Nutritional Therapy and Self Blood Glucose Monitoring

Phase 4
Completed
Conditions
Glycemic controlReduction of body weightLipid control
Medical nutrition therapy
Self blood glucose monitoring
type 2 diabetes
Registration Number
TCTR20141208001
Lead Sponsor
Faculty of Medicine, Srinakharinwirot University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. diagnosis of type 2 diabetes
2. Hemoglobin A1C more than 6.5 % within 3 months before enrollment

Exclusion Criteria

1. Hemoglobin A1C more than 9% within 3 months before enrollment
2. insulin or Glucagon-like peptide-1 agonist users
3. Liver cirrhosis
4. Pregnancy or expected to pregnant within 1 year
5. Receive tube feeding
6. Glomerular filtration rate less than 60 ml/min/1.73m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1C 12 and 24 weeks after start medical nutritional therapy %/ blood test
Secondary Outcome Measures
NameTimeMethod
Fasting plasma glucose 12 and 24 weeks after start medical nutritional therapy mg/dL blood test,Body weight 12 and 24 weeks after start medical nutritional therapy Kilograms,Low Density Lipoprotein-cholesterol 12 and 24 weeks after start medical nutritional therapy mg/dL blood test,Triglyceride 12 and 24 weeks after start medical nutritional therapy mg/dL blood test
© Copyright 2025. All Rights Reserved by MedPath